Aprepitant versus metoclopramide, both combined with dexamethasone, for preventing cisplatin-induced delayed emesis: A randomized, double-blind study.
0301 basic medicine
0303 health sciences
03 medical and health sciences
14. Life underwater
3. Good health
DOI:
10.1200/jco.2014.32.15_suppl.9503
Publication Date:
2019-01-03T17:38:23Z
AUTHORS (14)
ABSTRACT
9503 Background: A combination of aprepitant, a 5-HT3 receptor antagonist, and dexamethasone is recommended for the prophylaxis of cisplatin-induced nausea and vomiting in acute phase, and aprepita...
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....